Viswa Colluru

Researcher · Founder · Investor

Now Founder, Enveda

Latest on AI4S.fyiTimeline · Oct 27Across its runs, Enveda's document reviewer raised all 11 issues human reviewers found in 1,061 pages of batch records, and 7 they had not

Account links back to enveda.com · Avatar from their X account, taken 2026-09-28

Investment relationships shown here are limited to companies and funding rounds tracked by AI4S.fyi; they are not a complete investor portfolio.

Affiliations

Current

Founder · Envedasince 2019biospace.com ↗

Also named in the companies' announcements: Recursion

Current roles come from these dated records, not from the bio below. Each links the page it was read from.

About

Viswa Colluru is the founder and chief executive of Enveda. He was previously the first innovation scientist and product manager at Recursion, where he also set up its portfolio and early commercial team. He earned a bachelor's in biotechnology in India in 2011 and his PhD in UW-Madison's cellular and molecular biology programme in 2016, working on candidate immunotherapies.

Read on 2026-09-29; for current roles see Affiliations above. Read at: bigs.bio.org ↗ · enveda.com ↗ · mcneellab.com ↗ · ecals.cals.wisc.edu ↗

Founded

EnvedaDrug discovery · 2019 · 9 rounds on record · disclosed $820.9M · Series E $311M
Background: Recursion (first innovation scientist and product manager) (as the company's own announcements put it)
Backed byCatalio Capital Management Premji Invest Kinnevik FPV Dimension Lux Capital

Linked funding records

NoetikDrug discovery · Seed · 2023-09-07 · $14M
Angel investor · source ↗

On the timeline

Something wrong or missing on this page? Tell me and it will be fixed or removed. Contact →